EAM
DFTX

Empery Asset Management’s Definium Therapeutics DFTX Stock Holding History

Empery Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$656K Buy
+187,500
New +$1.8M 3.9% 7

Other funds holding DFTX

DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Empery Asset Management's DFTX Position: Q3 2022 in Review

Empery Asset Management opened a new position in Definium Therapeutics (DFTX) in Q3 2022: 187,500 shares worth $656K. The stake represents 3.9% of the portfolio and ranks #7 among its holdings.

101 funds tracked by Wall St. Rank hold DFTX as of Q3 2022.

  • Empery Asset Management held 187,500 shares of Definium Therapeutics worth $656K as of Q3 2022.
  • Definium Therapeutics was a new Empery Asset Management position in Q3 2022.
  • Definium Therapeutics made up 3.9% of Empery Asset Management's portfolio in Q3 2022, its #7 holding.
  • 101 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.